Champions Oncology (CSBR) Posts Narrower Q1 Loss
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.07 --0%
Financial Fact:
Cost of personalized oncology solutions: 474K
Today's EPS Names:
USDP, AFIB, BTTX, More
Financial Fact:
Cost of personalized oncology solutions: 474K
Today's EPS Names:
USDP, AFIB, BTTX, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q1 EPS of ($0.15), versus ($0.24) reported last year. Revenue for the quarter came in at $3.7 million, versus $2.8 million reported last year.
Reaffirms FY17 outlook.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Empire Petroleum posts $11.1M revenue in Q2 2026, narrows net loss
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
